Tulisibaike, B.; Yang, T.-Y.; Gu, W.-J.; Liu, H.; Wang, Y.-H.; Yang, J.-Q.; Wang, T.; Ding, S.-M.; Cai, R.-X.; Wang, Y.-J.;
et al. Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System. Vaccines 2026, 14, 524.
https://doi.org/10.3390/vaccines14060524
AMA Style
Tulisibaike B, Yang T-Y, Gu W-J, Liu H, Wang Y-H, Yang J-Q, Wang T, Ding S-M, Cai R-X, Wang Y-J,
et al. Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System. Vaccines. 2026; 14(6):524.
https://doi.org/10.3390/vaccines14060524
Chicago/Turabian Style
Tulisibaike, Bagejiang, Tian-Yi Yang, Wen-Jun Gu, Huan Liu, Yuan-Hui Wang, Jin-Qi Yang, Tong Wang, Si-Miao Ding, Rong-Xue Cai, Yuan-Jie Wang,
and et al. 2026. "Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System" Vaccines 14, no. 6: 524.
https://doi.org/10.3390/vaccines14060524
APA Style
Tulisibaike, B., Yang, T.-Y., Gu, W.-J., Liu, H., Wang, Y.-H., Yang, J.-Q., Wang, T., Ding, S.-M., Cai, R.-X., Wang, Y.-J., Wang, W., Pan, H.-X., Shao, F., & Su, Y.-W.
(2026). Post-Marketing Safety of mRNA Vaccines: A Real-World Study Integrating Literature Case Reports and Vaccine Adverse Event Reporting System. Vaccines, 14(6), 524.
https://doi.org/10.3390/vaccines14060524
